Eye Catching Stocks: Barrick Gold Corporation (NYSE:ABX), Can-Fite BioPharma Ltd. (NYSEMKT:CANF), Revlon, Inc. (NYSE:REV), Globus Medical, Inc. (NYSE:GMED), Hess Corporation (NYSE:HES)

On 22 February, Barrick Gold Corp (NYSE: ABX), the world’s largest gold miner, said it would spend a total of about $2 billion on projects in Nevada and Peru for construction starting 2019. The miner also said it would redeem up to $750 million in notes to help cut debt by at least $2 billion this year.

Barrick Gold Corporation (NYSE:ABX) belongs to Basic Materials sector. Its net profit margin is -31.40% and weekly performance is 0.89%. On last trading day company shares ended up at $13.58. Barrick Gold Corporation (NYSE:ABX) distance from 50-day simple moving average (SMA50) is 38.60%.

Can-Fite BioPharma Ltd. (NYSEMKT:CANF) shares increased 6.48% in last trading session and ended the day at $2.30. Can-Fite BioPharma Ltd. (NYSEMKT:CANF) quarterly performance is -34.29%.

On 26 February, Revlon, Inc. (NYSE:REV) reported Total Company net sales were $521.9 million in the fourth quarter of 2015, a growth of 4.2%, or 9.8% on an XFX basis, over the quarter ended December 31, 2014 (the “prior year quarter”). On a full year basis, total Company net sales were $1,914.3 million in 2015, a decline of 1.4%, or a growth of 4.9% on an XFX basis. Total Company Adjusted EBITDA was $125.6 million in the fourth quarter of 2015, a growth of 16.4%, or 21.8% on an XFX basis, over the prior year quarter. On a full year basis, total Company Adjusted EBITDA was $377.5 million in 2015, a growth of 3.4%, or 7.0% on an XFX basis;

On 02 March, Revlon, Inc. (NYSE:REV) shares moved down -1.11% and was closed at $35.57. REV EPS growth in last 5 year was -4.20%. Revlon, Inc. (NYSE:REV) year to date (YTD) performance is 27.77%.

On 24 February, Globus Medical, Inc. (NYSE:GMED) reported Net income for the year ending December 31, 2015 was $112.8 million, or $1.17 per diluted share, as compared to $92.5 million, or $0.97 per diluted share, for 2014. For the quarter ending December 31, 2015, net income was $37.6 million, or $0.39 per diluted share, as compared to $27.6 million, or $0.29 per diluted share, for 2014.

Globus Medical, Inc. (NYSE:GMED) ended the last trading day at $25.31. Company weekly volatility is calculated as 3.31% and price to cash ratio as 10.10. Globus Medical, Inc. (NYSE:GMED) showed a weekly performance of 6.61%.

Hess Corp. (NYSE: HES) declared a quarterly dividend of $0.25 per share, or $1 annualized. The dividend will be payable on March 31, 2016, to stockholders of record on March 17, 2016, with an ex-dividend date of March 15, 2016.

Hess Corporation (NYSE:HES) shares increased 5.89% in last trading session and ended the day at $46.92. HES Gross Margin is 77.90% and its return on assets is -8.60%. Hess Corporation (NYSE:HES) quarterly performance is -20.08%.

Leave a Reply

Your email address will not be published. Required fields are marked *